Mannatech (NASDAQ:MTEX) Share Price Crosses Below 200 Day Moving Average – Time to Sell?

Mannatech, Incorporated (NASDAQ:MTEX) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.95 and traded as low as $5.50. Mannatech shares last traded at $5.70, with a volume of 7,293 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 26th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Mannatech Stock Performance

The company has a quick ratio of 0.59, a current ratio of 1.09 and a debt-to-equity ratio of 0.48. The business has a 50 day simple moving average of $5.24 and a two-hundred day simple moving average of $6.95. The firm has a market cap of $11.00 million, a PE ratio of -0.85 and a beta of 0.72.

Mannatech (NASDAQ:MTEX) last released its earnings results on Thursday, May 14th. The company reported $0.49 earnings per share for the quarter. The business had revenue of $24.92 million for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.

Insider Activity at Mannatech

In other news, Director Kevin Andrew Robbins purchased 7,100 shares of the business’s stock in a transaction dated Tuesday, May 19th. The shares were purchased at an average price of $4.17 per share, for a total transaction of $29,607.00. Following the completion of the purchase, the director owned 33,333 shares in the company, valued at approximately $138,998.61. This represents a 27.07% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Insiders acquired a total of 14,903 shares of company stock worth $62,155 in the last 90 days. Company insiders own 41.50% of the company’s stock.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.